We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Statins Carry Small Risk Of Diabetes, FDA Warns

Law360, New York (February 28, 2012, 7:12 PM EST) -- Patients who take cholesterol-lowering drugs known as statins, some of the most popular drugs in the country, may be at a slightly higher risk of high blood sugar levels and Type 2 diabetes, the U.S. Food and Drug Administration said Tuesday.

Statins, a class of drug that includes Pfizer Inc.'s Lipitor, will be required to carry a warning of what the FDA said was “a small increased risk” of hyperglycemia and diagnosis of Type 2 diabetes.

The FDA said it was also changing the labeling requirements...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.